--- title: "\"Warning Signal of Earnings Decline\": Star Group is expected to turn from profit to loss in the middle of the year, with a loss of approximately 30 million yuan." type: "News" locale: "en" url: "https://longbridge.com/en/news/96474644.md" description: "Star Group issues profit warning, expecting a mid-year loss of approximately 30 million yuan as of the end of June, compared to a profit of 61 million yuan in the same period last year. The loss is mainly due to a decrease in property sales revenue compared to approximately 10 million yuan in the same period last year." datetime: "2023-08-30T01:04:59.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/96474644.md) - [en](https://longbridge.com/en/news/96474644.md) - [zh-HK](https://longbridge.com/zh-HK/news/96474644.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/96474644.md) | [繁體中文](https://longbridge.com/zh-HK/news/96474644.md) # "Warning Signal of Earnings Decline": Star Group is expected to turn from profit to loss in the middle of the year, with a loss of approximately 30 million yuan. Star Group (01560.HK) issued a profit warning, expecting a mid-year loss instead of a profit by the end of June, with a loss of approximately 30 million yuan, compared to a profit of 61 million yuan in the same period last year. The loss is mainly due to a decrease in property sales revenue from approximately 150 million yuan in the same period last year to approximately 119 million yuan, as well as the absence of fair value gains from investment properties in this period, compared to approximately 51 million yuan in the same period last year. (cy/u) ### Related Stocks - [STAR GROUP ASIA (01560.HK)](https://longbridge.com/en/quote/01560.HK.md) ## Related News & Research - [A C-Suite executive at Pop Mart's biggest Chinese competitor explains what goes into making a hit toy like Labubu](https://longbridge.com/en/news/281606541.md) - [Starfighters Space Delays Annual 10-K Filing](https://longbridge.com/en/news/281397627.md) - [Pop Mart’s $33 Billion Rout Casts Doubt on Life After Labubu](https://longbridge.com/en/news/281434908.md) - [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/en/news/281325910.md) - [22:00 ETHEARTS ON FIRE CELEBRATES 30 YEARS OF BRILLIANCE WITH NEW GLOBAL CAMPAIGN WHAT'S YOUR SIGNATURE?](https://longbridge.com/en/news/281450272.md)